124 related articles for article (PubMed ID: 11672959)
21. Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis.
Ulubaş B; Sahin G; Ozer C; Aydin O; Ozgür E; Apaydin D
Clin Rheumatol; 2004 Jun; 23(3):249-51. PubMed ID: 15168156
[TBL] [Abstract][Full Text] [Related]
22. Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.
Quallich LG; Greenson J; Haftel HM; Fontana RJ
BMC Gastroenterol; 2001; 1():8. PubMed ID: 11570976
[TBL] [Abstract][Full Text] [Related]
23. Sulfasalazine-induced hypersensitivity: a case report of DRESS syndrome.
Yeşilova Z; Kantarcioğlu M; Erçin CN; Safalioğlu M; Kilciler G; Koç E; Atli M; Uygun A
Turk J Gastroenterol; 2009 Dec; 20(4):298-9. PubMed ID: 20084578
[No Abstract] [Full Text] [Related]
24. Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.
Kümmerle-Deschner J; Dannecker G
Acta Paediatr; 1995 Aug; 84(8):952-4. PubMed ID: 7488828
[TBL] [Abstract][Full Text] [Related]
25. Drug-induced bilateral transient myopia with the sulphonamide sulphasalazine.
Santodomingo-Rubido J; Gilmartin B; Wolffsohn JS
Ophthalmic Physiol Opt; 2003 Nov; 23(6):567-70. PubMed ID: 14622362
[TBL] [Abstract][Full Text] [Related]
26. Sulphasalazine lung toxicity: report of two cases.
Karmakar GC; Wong CA; Horwood F; Anderson G
N Z Med J; 2010 Aug; 123(1320):86-7. PubMed ID: 20720607
[No Abstract] [Full Text] [Related]
27. [Toxic epidermal necrolysis during therapy with sulphasalazine in a patient with arthritis. Case report].
Rachwał-Siek K; Ponikowska M; Wiland P
Wiad Lek; 2011; 64(4):283-7. PubMed ID: 22533153
[TBL] [Abstract][Full Text] [Related]
28. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA.
Gunnarsson I; Nordmark B; Hassan Bakri A; Gröndal G; Larsson P; Forslid J; Klareskog L; Ringertz B
Rheumatology (Oxford); 2000 Aug; 39(8):886-93. PubMed ID: 10952745
[TBL] [Abstract][Full Text] [Related]
29. Sulfasalazine-Induced Toxic Epidermal Necrolysis: A Challenging Case During the COVID-19 Pandemic.
Shahidi-Dadras M; Shahrigharahkoshan S; Yazdi E; Fatemi A; Mahboubi-Fooladi Z; Dadkhahfar S
Adv Emerg Nurs J; 2021 Jul-Sep 01; 43(3):194-197. PubMed ID: 34397495
[TBL] [Abstract][Full Text] [Related]
30. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years.
Gordon MM; Porter DR; Capell HA
Ann Rheum Dis; 1999 May; 58(5):288-90. PubMed ID: 10225813
[TBL] [Abstract][Full Text] [Related]
31. Migratory pulmonary infiltrates in a patient with rheumatoid arthritis.
Mehandru S; Smith RL; Sidhu GS; Cassai N; Aranda CP
Thorax; 2002 May; 57(5):465-7. PubMed ID: 11978928
[TBL] [Abstract][Full Text] [Related]
32. Abrupt occurrence of high fever and rash in a patient treated with sulphasalazine for psoriatic arthritis.
Fischetti F; Gerloni R; Bardelli M; Carretta R
Minerva Med; 2003 Dec; 94(6):437-44. PubMed ID: 14976471
[TBL] [Abstract][Full Text] [Related]
33. Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis.
Walker EM; Carty JE
Br J Rheumatol; 1994 Feb; 33(2):175-6. PubMed ID: 7909272
[TBL] [Abstract][Full Text] [Related]
34. [A case of salazosulfapyridine induced hypersensitivity syndrome].
Orita M; Katakura Y; Kobayashi M; Ishii T; Watanabe Y; Yotsuyanagi H; Suzuki M; Itoh F
Nihon Shokakibyo Gakkai Zasshi; 2005 May; 102(5):600-4. PubMed ID: 15920959
[No Abstract] [Full Text] [Related]
35. Infectious mononucleosis-like syndrome induced by salazosulfapyridine in a patient with rheumatoid arthritis.
Furukawa K; Ohtani T; Furukawa F; Suzuki Y
Mod Rheumatol; 2007; 17(6):492-5. PubMed ID: 18084702
[TBL] [Abstract][Full Text] [Related]
36. A case of severe pulmonary infiltration with eosinophilia (PIE) syndrome induced by sulphasalazine.
Haroon M; Harney S
Int J Rheum Dis; 2012 Dec; 15(6):e150-2. PubMed ID: 23253243
[No Abstract] [Full Text] [Related]
37. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
van Riel PL; van Gestel AM; van de Putte LB
Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
[TBL] [Abstract][Full Text] [Related]
38. A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis.
Augusto JF; Sayegh J; Simon A; Croue A; Chennebault JM; Cousin M; Subra JF
Nephrol Dial Transplant; 2009 Sep; 24(9):2940-2. PubMed ID: 19509026
[TBL] [Abstract][Full Text] [Related]
39. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial.
Haagsma CJ; van Riel PL; de Jong AJ; van de Putte LB
Br J Rheumatol; 1997 Oct; 36(10):1082-8. PubMed ID: 9374925
[TBL] [Abstract][Full Text] [Related]
40. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
